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Abstract
The development of a technique to induce the transformation of somatic cells to a pluripotent state via the ectopic
expression of defined transcription factors was a transformational event in the field of regenerative medicine. The
development of this technique also impacted ophthalmology, as patient-specific induced pluripotent stemcells (iPSCs) may
be useful resources for some ophthalmological diseases. The lens is a key refractive element in the eye that focuses images
of the visual world onto the retina. To establish a new model for drug screening to treat lens diseases and investigating lens
aging and development, we examined whether human lens epithelial cells (HLECs) could be induced into iPSCs and if lens-
specific differentiation of these cells could be achieved under defined chemical conditions. We first efficiently
reprogrammed HLECs from age-related cataract patients to iPSCs with OCT-4, SOX-2, and KLF-4. The resulting HLEC-
derived iPS (HLE-iPS) colonies were indistinguishable from human ES cells with respect to morphology, gene expression,
pluripotent marker expression and their ability to generate all embryonic germ-cell layers. Next, we performed a 3-step
induction procedure: HLE-iPS cells were differentiated into large numbers of lens progenitor-like cells with defined factors
(Noggin, BMP and FGF2), and we determined that these cells expressed lens-specific markers (PAX6, SOX2, SIX3, CRYAB,
CRYAA, BFSP1, and MIP). In addition, HLE-iPS-derived lens cells exhibited reduced expression of epithelial mesenchymal
transition (EMT) markers compared with human embryonic stem cells (hESCs) and fibroblast-derived iPSCs. Our study
describes a highly efficient procedure for generating lens progenitor cells from cataract patient HLEC-derived iPSCs. These
patient-derived pluripotent cells provide a valuable model for studying the developmental and molecular biological
mechanisms that underlie cell determination in lens development and cataract pathophysiology.
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Introduction
Age-related cataracts are one of the most prevalent ocular
conditions and are responsible for nearly half of the cases of
blindness worldwide [1]. The pathogenesis of cataracts is complex
and involves both genetic and environmental factors. In contrast
to the cellular and molecular complexities of most ocular tissues,
the lens is a relatively simple structure. The lens is one of the most
promising tissues for aging studies, due to the ease of obtaining
lens epithelial and fiber cells, as well as the relative molecular
simplicity of fully differentiated fiber cells [2]. Additionally, the
lens is as accessible system for examining the fundamental aspects
of embryonic induction [3]. Developmental defects in the lens are
major causes of blindness and visual impairment among children.
Because many of the pathways required for lens formation are also
important for lens maintenance, a detailed understanding of lens
development will provide a rational basis for the treatment of
childhood cataract and may shed light on the lens-associated
diseases observed during the aging process.
However, a systematic approach for studying human cataracts
has been hampered by the lack of appropriate human-derived
models and limitations of human primary lens culture [4]. One
possible method for circumventing these issues is to induce human
ES cells (hESCs) to differentiate toward lens progenitors and
mature lens cells [5,6]. The establishment of efficient differenti-
ation procedures for the generation of lens cells from hESCs is an
important step for understanding human embryonic lens devel-
opment and related diseases. However, the use of human embryos
is ethically controversial and may lead to tissue rejection, thereby
hindering the potential application of hESCs. In addition, it is
difficult to generate disease-specific ES cells, which are required
for their effective application in clinical contexts. An alternative
approach for the generation and study of pluripotent cells was
recently described, which consisted of inducing a pluripotent status
in somatic cells by direct reprogramming [7]. Induced pluripotent
stem (iPS) cells generally exhibit a normal karyotype, are
transcriptionally and epigenetically similar to embryonic stem
(ES) cells and maintain the capacity to differentiate into derivatives
of all three germ layers. The transplantation of different types of
cells or tissues derived from iPS cells has recently become possible.
The induction of pluripotency can be achieved by ectopically
expressing factors known to be highly expressed in ES cells.
Specifically, the transduction of four genes encoding the
transcription factors OCT-4, SOX-2, C-Myc, and KLF-4 is
generally used to reset the epigenetic and transcriptional status of
somatic cells to those of pluripotent cells, which are functionally
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approach in human cells has enormous potential, allowing for the
generation of patient-specific pluripotent stem cells for the study
and amelioration of human diseases [12]. Somatic cell repro-
gramming has been performed using numerous somatic sources
with variable kinetics and efficiencies [13,14]. Therefore, it may be
possible to efficiently generate lens progenitor cells from cataract
patient-specific iPS cells that would aid studies concerning both
lens development and mechanisms of cataractogenesis.
There are currently no patient-specific models for the mechanis-
tic exploration of lens development and cataract formation.
Furthermore, no research has been conducted to determine
whether human lens epithelial cells (HLECs) from cataract patients
may be induced into iPS cells or whether these iPSCs may
subsequently be differentiated into lens progenitor cells under
defined chemical conditions. To address these questions, we
generated patient-specific iPS cells from lens epithelial cells. Next,
we differentiated these iPSCs and ESCs into lens progenitor cells
using a 3-stage procedure of sequential inhibition and activation of
the FGF, TGF-b and Wnt signaling pathways. Additionally, we
analyzed the expression of epithelial mesenchymal transition(EMT)
markers, key lens regulatory genes and structural genes during lens
development from iPS and ES cells. Our results demonstrate that
patient–specific iPSCs can be used to generate lens cells efficiently.
Materials and Methods
Cell culture
Human lens epithelial cells were isolated from age-related
cataract patients at the Eye and ENT Hospital of Fudan
University. We thoroughly reviewed the patients’ onset age,
symptoms and family history. No evidence suggested that their
cataracts were caused by congenital, traumatic or metabolic
factors. The circular piece of the anterior capsule with the LECs
attached was obtained by capsulotomy during cataract surgery
and cultured directly without dispersion of the cells. After circular
capsulorhexis, a section of the anterior capsule measuring
approximately 5 mm in diameter was touched with an irriga-
tion/aspiration tip and withdrawn from the eye by aspiration. The
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, Invitrogen, Grand Island, NY, USA) containing
15% fetal bovine serum (FBS) (Gibco, Invitrogen, Auckland, NZ).
Skin biopsy samples were also obtained from these patients,
digested with trypsin for 30 minutes and plated in a dish with
DMEM+10% FBS Medium. 293T cells (ATCC, Manassas, VA,
USA) were cultured in DMEM containing 10% fetal calf serum
(FCS) [15]. The research followed the tenets of the Declaration of
Helsinki, and written informed consent was obtained from the
subjects following an explanation of the nature and possible
consequences of the study. This study was approved by the Eye
and ENT Hospital of Fudan University Ethical Committee (ID:
KJ2010-41). Human H9 ES cells (Wicell) and iPSCs were cultured
as previously described [16] and fully characterized using similar
methodologies and criteria as described elsewhere.
Plasmids and virus preparation
The lentiviral vectors obtained from Addgene were as follows:
plenti-hOCT4, plenti-hSOX2 and plenti-hKLF4. The packaging
plasmids (pCMV-gag-pol-PA and pCMV-VSVg) were generously
provided by Dr. Trono of Geneva University. Lentivirus was
collected 48 hours following cotransfection of the plasmids in
293T cells. Transfections were performed using Lipofectamine
(Invitrogen, Carlsbad, CA, USA) in accordance with the
manufacturer’s recommendations.
iPS cells generation
HLECs and human fibroblast cells were infected at passage 2.
For viral transduction, 1610
6 HLECs and fibroblast cells were
seeded on 60 mm gelatin-coated dishes. After the cells had spread
evenly on the culture dishes, a solution of the three viruses was
added to the medium with polybrene (Sigma, St. Louis, MO,
USA, 8 mg/ml) for 48 hours. On the fifth day, the infected
fibroblast cells were replated onto irradiated mouse embryonic
fibroblasts (MEFs). After seven days, the DMEM medium was
replaced with the standard human ES cell culture medium (Gibco,
Invitrogen, Grand Island, NY, USA), and small colonies emerged
in the culture dish. Single colonies were picked two days later and
cultured until they grew into large colonies.
Differentiation of iPS and ES cells
H9 human ES cells were cultured on MEFs in DMEM/F-12
(Gibco, Invitrogen, Grand Island, NY, USA) supplemented with
ES medium. The culture medium was refreshed every two days,
and the cells were passaged once a week. Cell differentiation was
induced by the sequential administration of individual or specific
combinations of growth factors using a 3-step induction procedure
[6]: 1) administration of 100 ng/ml Noggin (R&D) from d 0 to 5;
2) a combination of 100 ng/ml bFGF (R&D), 20 ng/ml BMP4
(R&D) and 20 ng/ml BMP7 (R&D) from d 5 to 15; and 3) a
combination of 100 ng/ml FGF2 (R&D) and 20 ng/ml Wnt-3a
(R&D) from d 15 to 30.
Real-time PCR
Total RNA was isolated using the Trizol Reagent (Invitrogen,
Gaithersburg, MD, USA) and reverse-transcriped using the
SuperScript II Reverse Transcriptase kit (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s recommendations.
Real-time PCR analysis was performed using the SYBR-Green
PCR Master Mix (Applied Biosystems, Foster City, CA, USA).
The expression levels of individual genes were normalized to ß-
actin levels and are shown relative to the control samples as
indicated. The primer sequences used in the real-time PCR assays
are listed in Table 1.
Immunocytochemistry
The cultured cells were fixed in situ in 4% paraformaldehyde
(PFA) for 30 min. Following 3 washes with PBS, the cells were
permeabilized in 0.2% Triton X-100 for 30 min, blocked for
1 hour in 10% FCS and 1% BSA in PBS and incubated overnight
at 4uC with primary antibodies against NANOG, OCT-4, SSEA-
3, SSEA-4, TRA-60, TRA-81, PAX6, a-crystallin andb-crystallin
(Chemicon, USA, 1:200) in 1% BSA in PBS. On the following
day, the cells were washed 3 times with PBS and incubated with
fluorescence-conjugated secondary antibodies (anti-rabbit Cy3,
Jackson ImmunoResearch, USA, 1:200) and DAPI in 1% BSA in
PBS for 1 h at room temperature. Images were obtained with an
inverted Olympus IX81 microscope (Olympus, Tokyo, Japan).
Western Blotting
Lenses from a 22-yr-old male, 44-yr-old male and 65-yr-old
male were thawed on ice and homogenized in PBS, pH 7.2. The
homogenates were centrifuged at 5000 rpm for 5 min, and the
soluble portion of the lens was retained. Cells were harvested into
1 ml of lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% (w/
v) Triton X-100 (Sigma, St. Louis, MO, USA), 0.1% (w/v) SDS
supplemented with a cocktail of protease inhibitors (Roche
Diagnostics, Burgess Hill, UK). Each lane was loaded with
20 mg of total protein. The gels were blotted onto a nitrocellulose
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overnight at 4uC: anti-human PAX6 (Chemicon, USA, 1:1000),
anti-connexin-43 (Santa Cruz, USA, 1:1000), anti-fibronectin
(Santa Cruz, USA, 1:1000), anti-CRYAB (Chemicon, USA,
1:1000), anti-CRYAA (Chemicon, USA, 1:1000) and anti-b-actin
(Abcam, USA, 1:1000). The blots were then incubated for 1 hour
with secondary anti-rabbit antibody conjugated to HRP (Santa
Cruz, USA, 1:2000). The membranes were developed using the
ECL western blotting detection system (Amersham, UK) accord-
ing to the manufacturer’s protocol.
Whole-genome expression analysis
A total cDNA microarray was performed using a HG-U133-2
array (Affymetrix) at the Shanghai microarray core. Invariant set
normalization was used to normalize arrays at the probe level, and
the model-based method was used to calculate expression values.
A 20% presence call was used to filter the genes for clustering,
resulting in 20,001 probe sets representing individual genes. A
hierarchical clustering analysis was performed to distinguish arrays
with similar expression patterns.
Teratoma assay
To test for teratoma formation, iPS cell lines were injected into
nude mice. Ethical approval was obtained prior to the com-
mencement of the study from the Council on Animal Care and the
Animal Use Subcommittee at the Eye and ENT Hospital of Fudan
University (ID: KY2010-68). The ‘‘Principles of Laboratory
Animal Care’’ were followed, and every effort was made to
minimize the suffering and number of animals used. Briefly,
1610
6 iPS cells in 50 mL of ES cell medium were intradermally
injected into the mice. The mice were subsequently monitored for
teratoma formation and euthanized 6–12 weeks following the
injection. The collected teratomas were analyzed using hematox-
ylin and eosin staining.
Statistical analysis
All statistical analyses were performed with SPSS for Windows
(ver 13.0, SPSS, Inc, Chicago, IL, USA). The results are shown as
the mean6standard deviation (SD) or the standard error of the
mean (SEM), as indicated. The values obtained from the stem cell
array were analyzed using the Pearson correlation coefficient as a
measure of similarity. The remaining statistical analyses were
performed using an unpaired two-tailed Student’s t-tests. P-
values,0.05 were considered to be statistically significant.
Results
Derivation of iPSCs from HLECs
To identify a strategy for generating iPSCs from HLECs, the
cultured HLECs from the cataract patient were infected with
lentiviruses carrying DNA constructs encoding KLF-4, OCT-4
and SOX-2 to generate induced pluripotent stem cells (HLEC-
iPSCs). This was a 56-year-old male patient diagnosed as age-
related cataract and there is no role of traumatic, metabolic or
genetic factors influencing the generation and differentiation of
this patient’s iPSCs. A schematic representation of the experi-
mental strategy used to reprogram the HLECs is shown in Fig. 1A.
The infected HLECs were plated onto MEFs on the fifth day
following infection (Fig. 1B). Colonies with an ES cell-like
morphology formed 12 days following infection (Fig. 1C). The
human H9 ES cell line was used as a positive control for
pluripotent stem cells (Fig. 1D). These HLEC-iPSCs were labeled
with the pluripotency marker alkaline phosphatase (AP) (Fig. 1E).
To compare iPS clone formation efficiency, HLEC and human
fibroblast cells were collected from three age-related cataract
Table 1. Primer sets for each human gene used in qRT-PCR assays.
Gene Forward primer Reverse primer
NANOG 59-GGGCCTGAAGAAAACTATCCA-39 59-TGCTATTCTTCGGCCAGTTGT-39
FGF-4 59-CGTTGATTAAGTCCCTGCCCT-39 59-TCAAGTTCGACCGTCTTCTCA-39
OCT-4 59-GGCCCGAAAGAGAAAGCG-39 59-ACCCAGCAGCCTCAAAATCCTC-39
NCAM 59-TGGCGAGCAGGATGCGACC-39 59-GGCATGGCAACGCACCACCA-39
TH 59-CCACAGGCCAAGGGCTTCCG-39 59-GGCACCTACCTGCCCTCTTACCA-39
GFAP 59-AAGGACGAGATGGCCCGCCA-39 59-TGGTGTCCAGGCTGGTTTCTCGA-39
AFP 59-AGCAGCTTGTTAAATCAACATGCA-39 59-ATTAACTTTGGTAAACTTTCTGACTCAGT-39
AMYLASE 59-ACCTCAACAGGTCAGAGATTGTCGT-39 59-TCCAGGCCACATGAGCTTGGA-39
SOX17 59-CCTCGGGGCATCTCAGTGCCTCA-39 59-CTCGGCGTTGTGCAGGTCTGG-39
PECAM 59-GCTGAGCGAGTCATGGCCCG-39 59-CGCGAAGCACTGCAGGGTCA-39
DESMIN 59-CCATGAGCCAGGCCTACTCGTCCAG-39 59-AACTCAGCGGGGAGCCGAGTG-39
SCL 59-TGGGTGGTCTGGGCTCAGGG-39 59-GCTCTGGTGTCAGGTCCTCATCG-39
PAX6 59-TTTGCCCGAGAAAGACTAGC-39 59-CATTTGGCCCTTCGATTAGA-39
SOX2 59-ATGATGGAGACGGAGCTGAA-39 59-GGGCTGTTTTTCTGGTTGC-39
SIX3 59-CCCACACAAGTAGGCAACTG-39 59-GTCCAATGGCCTGGTGCT-39
CRYAB 59-GTTCTTCGGAGAGCACCTGTT-39 59-GAGAGTCCAGTGTCAAACCAG-39
CRYAA 59-AAGGTGCAGGACGACTTTGT-39 59-GTGGAACTCACGGGAAATGT-39
BFSP1 59-CTCCAGCATCCATTGTGACGA-39 59-CGCAGTGTCTCAATCTGCTC-39
MIP 59-GTGCTGTATAGCGTTACCCCA-39 59-CTCGTCGTATGTGGCAAAGAT-39
b-actin 59-CGCACCACTGGCATTGTCAT-39 59-TTCTCCTTGATGTCACGCAC-39
doi:10.1371/journal.pone.0032612.t001
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staining was performed, revealing approximately 25 AP-positive
clones from 1610
6 HLEC cells and approximately 15 clones
formed from 1610
6 human fibroblast cells (Fig. 1F).
These results demonstrate that iPS clones were successfully
induced from the HLECs of the cataract patient with high
reprogramming efficiencies. HLEC-derived iPSCs colonies were
AP-positive and similar to human ES cells in terms of morphology.
HLEC-iPS cells share key expression markers and
morphology with hESCs
We randomly selected four clones from the induced cells
(named iPS1, iPS2, iPS3 and iPS4) origining from the 56-year-old
age-related cataract patient and compared the expression of key
markers and morphology between the HLEC-iPS clones and H9
human ES cell lines. The expression of ES cell markers was
examined in iPS and H9 ES clones using real-time PCR analysis
with primers targeting endogenous HESC-specific genes in the iPS
clones (OCT-4, NANOG, REX-1 and SOX-2) and vimentin,
which is an HLEC-specific gene. The RT-PCR results revealed
that the gene expression patterns of the iPS1 clone were largely
similar to those of hESCs (Fig. 2A). A genome-wide microarray
analysis was performed to compare the gene expression pattern of
HLEC-iPSCs, H9 ESCs and primary HLECs (Fig. 2B). A
hierarchical cluster analysis of 8030 orthologous human genes
was performed based on the signal ratios between the different cell
types (Fig. 2B). We also stained the iPS1 clone for the pluripotency
markers SSEA-4 (Fig. 2C), SSEA-3 (Fig. 2D), NANOG (Fig. 2E),
TRA-60 (Fig. 2F), TRA-81 (Fig. 2G) and OCT-4 (Fig. 2H). We
observed that these ES markers were highly expressed in the iPS1
clone. These data provide strong evidence that the HLEC-derived
iPS colonies were indistinguishable from human ES cells based on
the analysis of key markers, and the gene pattern of HLEC-iPSCs
was similar to that of ES cells but not that of primary HLECs. The
immunohistochemistry (ICH) results provide compelling evidence
that iPSCs share the majority of the promising ES cell
characteristics.
iPSCs are pluripotent and can differentiate into three
germ layers
We next assessed the pluripotency of iPSCs and their ability to
generate all embryonic germ layers. Real-time RT-PCR analysis
was performed to assess the expression of pluripotency genes in
HLEC-iPSCs clones (iPS1) and ESCs induced to differentiate
through embryoid body (EB)formation and subsequent plating
under the indicated conditions (BMP4, FBS, and retinoic acid
(RA)). The expression of these genes was determined relative to
GAPDH expression (Fig. 3A). EB differentiation resulted in the
downregulation of pluripotency markers OCT4 and NANOG.
The expression of marker genes for different germ layers was also
analyzed. The ectodermal markers examined were NACM, TH,
and GFAP; the endodermal markers were amylase, SOX7, and
AFP; and the mesodermal markers were PECAM, desmin, and
SCL. Although the degree of induction for these lineage markers
varied somewhat between HESC and iPS clones, the pattern was
consistent. For the immunofluorescence experiments, EBs were
generated by plating iPS1 clones onto adherent tissue culture
dishes (Fig. 3B). After 3 days, the dissociated EB cells were stained
by immunofluorescence for mesodermal (Fig. 3C: a-smooth
muscle actin (a-SMA)), ectodermal (Fig. 3D: Tuj-1), and
Figure 1. The derivation of induced pluripotent cells from HLECs. HLECs were infected with lentiviruses carrying DNA constructs encoding
KLF-4, OCT-4 and SOX-2 to generate induced pluripotent stem cells (HLEC-iPS). (A) A schematic representation of the experimental strategy used to
reprogram HLECs. (B) The infected HLECs were plated onto mouse embryonic fibroblasts (MEFs). Colonies with an ES cell-like morphology (C), which
appeared as early as 12 days following infection, and (D) H9 ES cell lines. (E) HLEC-iPSCs express pluripotency markers alkaline phosphatase (AP). (F)
HLECs can be induced to iPSCs with high efficiency compared with human fibroblast cells: HLEC and human fibroblast cells were collected from three
age-related cataract patients. After the iPS factors had been added for 14 days, AP staining was performed, revealing approximately 25 AP-positive
clones from 1610
6 HLEC cells and approximately 15 clones formed from 1610
6 human fibroblast cells.
doi:10.1371/journal.pone.0032612.g001
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germ layer. Additionally, following transplantation into nude mice,
human iPSCs formed teratomas (Fig. 3F) consisting of all three
germ layers, including ciliated columnar epithelium (endoderm,
Fig. 3G), cartilage islands (mesoderm, Fig. 3H) and primary neural
tube (ectoderm, Fig. 3I). Taken together, these results suggest that
typical HLEC-iPS cells exhibit the characteristic morphology and
key signaling responses of conventional HESCs and can be
differentiated into all of the germ lines.
iPSCs were efficiently induced to express lens progenitor
cell markers using the defined chemical factors
Our next goal was to determine whether these HLEC-derived
iPSCs could be further differentiated into lens progenitor cells. To
achieve lens-specific differentiation, we applied a 3-step induction
procedure, as reported by Yang et al [6]. We also analyzed 7 lens
progenitor and differentiation markers (PAX6, SOX2, SIX3,
CRYAB, CRYAA, BFSP1 and MIP) in HLEC-iPSCs and hESCs
from d 0 to d 30 (Fig. 4). The results indicated that several markers
(PAX6, BFSP1 and MIP) were upregulated in HLEC-iPSCs more
rapidly than in hESCs. However, the expression of the hESCs
marker SOX2 decreased rapidly in the HLEC-iPSCs. The
immunocytochemical analyses confirmed that the HLEC-iPSCs
have the capacity to differentiate into lens progenitor and primary
lens fibroblast cells using a 3-step induction procedure. This
finding was determined by the expression of PAX6 (Fig. 5 A, B) a-
crystallin (Fig. 5 C, D) and b-crystallin proteins (Fig. 5 E, F). By
using western blots to detect the expression levels of these markers,
we found comparable levels of these proteins in human lens and
iPS-induced cells (Fig. 5 G).From these data, we conclude that this
Figure 2. HLEC-iPSCs exhibit key HESC markers and HESC morphology. (A) Real-time RT-PCR analysis of ES markers in HLEC-iPS clones and
H9 ES clones. Primers were used that specifically recognize endogenous HESC-specific genes in iPS clones (OCT-4, NANOG, REX-1, SOX-2) and
vimentin, which is an HLEC-specific gene. (B) A microarray analysis was performed to compare the gene expression profiles of HLEC-iPSCs, a human
H9 ES cell line and primary HLECs. A hierarchical cluster analysis of 8030 orthologous human genes was performed based on the signal ratios. The
distances between the genetic profiles of the samples are shown. (C-H): Pluripotency marker staining (red) of the iPS1 clone, (C) SSEA-4, (D) SSEA-3,
(E) NANOG, (F) TRA-60, (G) TRA-81 and (H) OCT-4.
doi:10.1371/journal.pone.0032612.g002
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cells from patient-specific iPSCs.
HLE-iPS-derived lens cells display reduced EMT
EMT is the major cause of posterior capsule opacification
(PCO) after cataract surgery, a phenotypic conversion character-
ized by the sequential loss of epithelial markers (e.g., connexin-43)
and acquisition of mesenchymal cell markers (e.g., fibronectin).
Figure 6 shows a comparison between the human lens at different
ages (Fig. 6A) and the iPS- and ES-induced lenses (Fig. 6B–D: B,
the HLEC-iPS-derived lens; C, human fibroblast-iPS-derived lens;
D, H9 ES cell line-derived lens). The expression of EMT markers
was analyzed by western blot. Connexin-43 was abundantly
expressed in the younger lens and HLEC-derived lens cells, and it
was significantly suppressed in the old lens, skin fibroblast and ES-
derived lens cells. In contrast, the expression of fibronectin was
significantly increased in the old lens, skin fibroblast and ES-
derived lens cells (Fig. 6E). These results show that the ES and
fibroblast-iPS-derived lens cells exhibited increased EMT; how-
ever the EMT rate in HLE-iPS-derived lens cells was similar to
that of normal lens cells.
Discussion
This study describes a highly efficient procedure for generating
lens cells from patient-specific iPSCs. The ability of different hESC
and iPSC lines to differentiate into specific cell types has been
shown to vary by cell line. For example, foreskin iPS lines
spontaneously differentiate into retinal pigment epithelium (RPE)
cells at a lower rate than iPS lines from the eye [17]. The reason
for this difference is unclear, but it may contribute to the decision
of which iPS lines are used for research and treatment
Figure 3. The pluripotency of HLEC-iPS cells and up-regulation of ectodermal, endodermal, and mesodermal markers. (A) Real-time
RT-PCR analyses of pluripotency gene expression levels in iPS and control HESCs (H9) induced to differentiate via embryoid body (EB) formation and
subsequent plating under the indicated conditions (BMP4, FBS, and retinoic acid (RA)). The results were determined relative to GAPDH expression.
The y-axis represents the relative fold change upon differentiation. The expression of marker genes for different germ layers was analyzed. The
specificity of each marker for a given germ layer is indicated. (B) Phase-contrast images of EBs generated from iPS1 clones plated onto adherent tissue
culture dishes. (C–E) EB-dissociated cells stained by immunofluorescence for mesodermal (C: a-smooth muscle actin (a- SMA)), ectodermal (D: Tuj-1),
or endodermal (E: AFP) markers representing each embryonic germ layer. Hematoxylin and eosin staining of teratoma sections from iPSC-derived
teratomas is shown (F–I). (F) human iPSCs formed teratomas. (G) ciliated columnar epithelium (endoderm). (H) Cartilage islands (mesoderm). (I)
primary neural tube (ectoderm).
doi:10.1371/journal.pone.0032612.g003
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derived iPS (HLEC-iPS) cell colonies were indistinguishable from
human ES cells with respect to their morphology, gene expression
profile, expression of pluripotent markers and ability to generate
all three embryonic germ layers in vitro and in vivo. HLEC-iPS
can be highly and efficiently differentiated into large numbers of
lens progenitor cells through the use of defined factors (Noggin,
BMP and FGF2). The expression of lens-specific markers was
induced and maintained in these cells.
Lens research aims to gain insights into the cellular and
molecular basis of ophthalmological disease. Furthermore, the lens
serves as a valuable experimental system with which to address
fundamental biological questions. The lens is an encapsulated
avascular organ that focus light onto the retina. Millions of
individuals are blinded or exhibit visual impairment, due to
pathologies of the lens [18], and cataracts are among the leading
causes of blindness in elderly populations [1]. The distinct
architecture of the lens is established early in life and maintained
as the lens continues to grow [4]. This growth depends on the
controlled proliferation of lens epithelial cells and their precise
local differentiation into long and transparent fiber cells. Any
disruption to these normal cellular processes can disrupt lens
architecture, resulting in cataract formation [4]. Currently, surgery
is often the only successful treatment, although this approach it is
not without later complications that may lead to what is termed
secondary cataract [19]. A common complication following
surgery results from the aberrant behavior of the remaining lens
cells. These residual cells transform into pathological cell types,
which can impair vision yet again [20]. Current cataract research
primarily aims to identify the molecules and mechanisms involved
in the regulation of normal lens cell behavior. Cataract prevention
is also a vital topic in preventative medicine and offers hope to the
multitude of individuals worldwide who cannot be aided by
intraocular lens implantation. The patient-specific iPSCs described
here will open new avenues of research to study the molecular
mechanisms of patient-specific lens development. This technique
will also advance the study of iPS-derived lens cells isolated from
cataract patients. Because lens formation is critical to eye
development, this study will also aid in describing human
embryonic lens development, aging and related diseases.
Clearly, iPS technology provides a new method for establishing
a patient-specific model of lens development and disease. In 1901,
Hans Spemann introduced the concept of inductive interactions
by studying lens development [21]. Induction is a process by which
Figure 4. HLEC-iPS can be highly efficiently induced to express lens progenitor cell markers with defined chemical factors. Real-time
RT-PCR analysis of 7 lens differentiation markers (PAX6, SOX2, SIX3, CRYAB, CRYAA, BFSP1, and MIP) in iPSCs and ESCs from d 0 to 30 following the
initial plating. The results were calculated relative to the average Ct value of GAPDH. For details on the 3-step induction procedure, see Materials and
Methods.
doi:10.1371/journal.pone.0032612.g004
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cell population or tissue. Since the introduction of this concept,
several studies have sought to better understand the role of specific
signaling molecules, the interplay between different signals and
tissue interactions in regulating lens induction and patterning
events. This knowledge is not only important for understanding
normal lens development but also key to defining the general
mechanisms of cell specification and gaining a better understand-
ing of lens function and pathology. There is therefore a great need
for patient-specific disease models in clinical research. In our work,
we attempted to generate patient-specific lens cells using iPS
technology. The iPS cells share the majority of the therapeutic and
research potential of ESCs but lack the ethical and political
complications, as well as the immunological considerations [5].
These cells are also more clinically relevant for many applications
and are therefore an excellent choice for research in toxicology,
regenerative medicine and other fields. Pluripotent stem cells can
be generated by reprogramming patient somatic cells, and patient-
tailored iPS cells will be valuable for regenerative medicine
[6,22,23]. However, several obstacles must be overcome before
therapeutic applications of iPS cells for human diseases can be
implemented. One issue is the question of how to directly
differentiate iPS cells into specific donor cells. Other challenges to
using iPSCs include determining how to reprogram primary cells
from patients with diseases and showing that these reprogrammed
cells can be differentiated into cell types that function properly
upon transplantation into disease treatment models. Overcoming
these challenges may allow general human cell reprogramming
through the expression of defined factor to be an applicable
therapeutic approach.
Our data demonstrate that the transduction of defined factors
(OCT-4, SOX-2 and KLF-4) into patient-specific HLECs leads to
the formation of iPSCs with high reprogramming efficiencies. Our
analysis indicates that one iPS clone, iPS2, was only partially
reprogrammed to an ES cell state based on gene expression
profiles and the inability to form EBs. The iPSCs we generated via
the expression of defined factors in HLECs were highly similar to
HESCs in terms of both morphology and physiology. Next, we use
small molecules to induce the lens-specific differentiation of the
patient-specific iPSC. Multiple signal transduction pathways,
including FGF, TGF-b and Wnt, have been implicated in lens
development [3]. Some of these factors, such as FGF, have been
shown to have the same cell-growth promoting effect in an iPS
system [6]. Our results indicate that some markers (PAX6, BFSP1
and MIP) can be upregulated in differentiated HLEC-iPS cells
more rapidly than in hESCs; however, expression of the hESCs
marker SOX-2 decreased rapidly in the HLEC-iPSCs. PAX6 is a
key regulatory gene throughout lens development [23]. Our
technique for lens cell differentiation increased and maintained
PAX6, CRYAB and CRYAA expression, which was similar to the
effect observed in Yang’s study [6].
In vertebrates, lens progenitor cells originate from the
preplacodal region (PPR) [24,25]. PPR cells subsequently give
rise to other cell lineages, including the anterior pituitary, olfactory
epithelium, and inner ear [26]. The adult lens has a relatively
simple structure and is composed solely of epithelial and fiber cells.
The lens’s isolation from nerves and blood vessels in the adult
makes it a tractable model for investigating the mechanism of
epithelial cell regulation. Multiple signal transduction pathways,
including FGF, TGF-band Wnt, have been implicated in lens
development [27,28]. These studies have suggested that FGFs,
BMP4, BMP7, Noggin and Wnts might be excellent candidates for
lens cell differentiation from human ES cell cultures
[29,30,31,32,33]. Our results showed HLEC-derived iPS cells
can be highly efficiently induced to express lens progenitor and
primary lens fibroblast cell markers through the use of defined
chemical factors. The elevated expression of some markers (PAX6,
BFSP1, and MIP) can be detected when compared with lens cells
induced from H9 ES cells. We detected the expression of a
number of critical genes for lens development and maturation in
patient-specific iPSCs after differentiation and obtained similar
results to what was observed for hESC differentiation. In our
future work, we will attempt to define the induction conditions and
assay lens architecture and function.
Approximately 20–25% of patients undergoing cataract surgery
experience PCO within 2 years [34,35]. Emerging evidence
suggests that LECs can undergo an EMT that bears morpholog-
ical and molecular resemblance to forms of PCO [36,37]. A
hallmark of EMT in LECs is the loss of epithelial cell-cell gap
junctions caused by the downregulation of connexin-43 [38]. The
Figure 5. HLEC-iPSCs can be highly efficiently induced to
express mature lens cell markers during initial differentiation.
The expression of PAX6, a-crystallins and b-crystallins in HLEC-iPSCs
differentiated into lens progenitor cells at d 10 following infection is
shown. The immunofluorescent detection of PAX6 (red, A, B) is shown,
a- crystallin (red, C, D) andb-crystallin proteins (red, E, F). (G) Western
blot analysis of protein expression during the differentiation of HLEC-
iPSCs. Specific antibodies were used to detect expression of PAX6, a-
crystallin and b-crystallin. Expression of actin is shown as a loading
control.
doi:10.1371/journal.pone.0032612.g005
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channels, allowing the transmission of functional molecules, and
the expression of genes encoding functional proteins [39,40]. In
our study, extensive EMT was observed in both older individuals
and the ES/fibroblast-iPS-derived lens cells, while this transaction
was relatively low in the HLEC-iPS-derived cells, suggesting that
the HLEC-iPS-derived lens cells were more suitable for lens
regeneration than the ES/fibroblast-iPS cells.
Cataracts are a common human disease often observed in
animal models as well. Over the last several decades, considerable
progress has been made in identifying and characterizing many of
the molecules involved in normal lens biology and its pathology.
Much of this research has been made possible through the
establishment and use of lens models. However, a systematic
approach for studying human cataracts has been hampered by the
lack of appropriate human-derived models. Moreover, because of
the small size of the families available for detailed genetic
investigations, it is necessary to develop appropriate human-
derived models to identify the genes responsible for cataract
formation and to analyze the mechanisms leading to lens
opacification. There are several advantages of using patient-
specific HLEC-derived iPSCs regarding efficiency, convenience
and application value. First, several studies have demonstrated
that cells from the target tissue are more easily differentiated back
to their original source than other cells [17]. Therefore, iPSCs
from primary human lens epithelial cells should more efficiently
differentiate into lens cells than those from skin fibroblasts. We
compared the clone formation efficiency between HLECs and
fibroblasts and found that HLEC–derived iPSCs had higher
efficiency. Second, we found that fibroblast and human ES-
derived iPSCs could undergo an EMT during the chemically-
induced differentiation, which bears a morphological and
molecular resemblance to forms of PCO. However, we detected
reduced levels of EMT markers during HLEC-derived iPSC
differentiation, suggesting that HLEC-iPS may be more suitable
for clinical applications. Third, the piece of the anterior capsule
with the LECs attached to it was obtained by capsulotomy during
cataract surgery. This approach is a simple, convenient and safe
way to obtain primary cells. Based on our results, there was no
requirement to obtain patients’ skin fibroblasts through a second
method. Through this patient-specific model, we will be able to
further study how to inhibit cataract formation and better
understand the pathogenetics of congenital cataracts as well as
developmental lens defects, such as lenticular coloboma and
spherophakia. This human-derived model will serve as a powerful
tool to further our understanding of lens biology and pathology,
Figure 6. HLEC-derived lens cells exhibit characteristics of young lens cells with reduced EMT. Human lenses at different ages are shown
in Fig. 6A, and the morphology of the induced lenses are shown in Fig. 6B–D: (B) the HLEC-iPS-derived lens, (C) human fibroblast-derived lens, (D)
h9ES cell line-derived lens. The expression of EMT markers was revealed by western blot. Connexin-43 was abundantly expressed in younger lens cells
and HLEC-derived lens cells, while it was significantly suppressed in older lens, skin fibroblast and ES-derived lens cells. In contrast, the expression of
fibronectin was significantly increased in older lens, fibroblast and ES-derived lens cells (Fig. 6E).
doi:10.1371/journal.pone.0032612.g006
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capacity as new developments are realized, and putative
treatments for aberrant lens cell behavior are tested.
HLECs have generally been discarded in cataract operations. In
our study, we found that these cells were useful materials for the
production of cataract patient-specific iPSCs. These iPSCs can be
efficiently induced to differentiate into lens cells using defined
chemical conditions. Our research revealed that iPS cells that are
induced by OCT-4, SOX-2, and KLF-4 inherently express lens-
specific markers, indicating that these cells are valuable for lens
regeneration research. In this study, we present a technique for
reprogramming HLECs to pluripotent stem cells and the direct
differentiation of these cells into lens progenitor cells, thereby
artificially directing cell fate through the use of transcription
factors. It is necessary to study iPS lines from multiple patients and
compare these different iPS lines with different ES cell lines. We
will further investigate this human-derived model, thoroughly
characterize it and put it into effect in our future research. In
conclusion, we present a preliminary step towards the goal of
patient-specific model construction and lens regeneration based on
iPS technology and a three-step induction procedure. These
findings demonstrate the usefulness of this model for studying the
molecular mechanisms of human lens development and the
biology of lens cells differentiated from cataract patient-derived
iPSCs.
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